Analyst Price Targets — MTD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 14, 2026 10:42 am | — | Barclays | $1,500.00 | $1,345.89 | TheFly | Mettler-Toledo price target lowered to $1,500 from $1,550 at Barclays |
| February 9, 2026 2:32 pm | Kallum Titchmarsh | Morgan Stanley | $1,475.00 | $1,382.72 | StreetInsider | Mettler-Toledo (MTD) PT Lowered to $1,475 at Morgan Stanley |
| February 9, 2026 12:15 pm | Catherine Ramsey Schulte | Robert W. Baird | $1,445.00 | $1,373.57 | TheFly | Mettler-Toledo price target raised to $1,445 from $1,444 at Baird |
| December 15, 2025 11:29 am | — | Wells Fargo | $1,450.00 | $1,393.64 | TheFly | Mettler-Toledo price target raised to $1,450 from $1,400 at Wells Fargo |
| December 15, 2025 11:09 am | — | Susquehanna | $1,600.00 | $1,393.64 | StreetInsider | BofA Securities Upgrades Mettler-Toledo (MTD) to Buy |
| December 15, 2025 10:55 am | — | Barclays | $1,550.00 | $1,393.64 | TheFly | Mettler-Toledo price target lowered to $1,550 from $1,600 at Barclays |
| December 9, 2025 9:28 am | — | Goldman Sachs | $1,475.00 | $1,381.37 | TheFly | Mettler-Toledo initiated with a Neutral at Goldman Sachs |
| December 1, 2025 9:25 pm | Kallum Titchmarsh | Morgan Stanley | $1,550.00 | $1,468.09 | TheFly | Mettler-Toledo initiated with an Equal Weight at Morgan Stanley |
| October 7, 2025 10:40 am | — | Evercore ISI | $1,400.00 | $1,345.27 | TheFly | Evercore ups Mettler-Toledo price target, adds to 'Tactical Underperform' list |
| October 2, 2025 10:43 am | — | Barclays | $1,350.00 | $1,289.82 | TheFly | Mettler-Toledo price target raised to $1,350 from $1,325 at Barclays |
Latest News for MTD
Massachusetts Financial Services Co. MA reduced its holdings in Mettler-Toledo International, Inc. (NYSE: MTD) by 7.7% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 167,872 shares of the medical instruments supplier's stock after selling 13,995 shares during
Mettler-Toledo International, Inc. (NYSE: MTD - Get Free Report) has earned an average recommendation of "Moderate Buy" from the thirteen research firms that are currently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its first quarter 2026 financial results after the market close on Thursday, May 7, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the…
Aberdeen Group plc grew its stake in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 16.0% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,756 shares of the medical instruments supplier's stock after buying an additional 2,862 shares during
Canoe Financial LP lessened its holdings in Mettler-Toledo International, Inc. (NYSE: MTD) by 4.0% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 53,864 shares of the medical instruments supplier's stock after selling 2,260 shares during the period.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.